(Q42451980)

31 October 2017

AM630 is an inverse agonist at the human cannabinoid CB1 receptor (English)

1 reference

31 October 2017

0 references

0 references

0 references

Alexandros Makriyannis

2

object named as

A Makriyannis

1 reference

31 October 2017

R S Landsman

1

1 reference

31 October 2017

H Deng

3

1 reference

31 October 2017

P Consroe

4

1 reference

31 October 2017

W R Roeske

5

1 reference

31 October 2017

H I Yamamura

6

1 reference

31 October 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

31 October 2017

1 reference

31 October 2017

62

1 reference

31 October 2017

PL109-13

1 reference

31 October 2017

9

1 reference

AM630, a competitive cannabinoid receptor antagonist

31 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901187-9

AM630 is a competitive cannabinoid receptor antagonist in the guinea pig brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901187-9

SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901187-9

Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901187-9

A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901187-9

SR141716A is an inverse agonist at the human cannabinoid CB1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2901187-9

10.1016/S0024-3205(97)01187-9

7 January 2021

Identifiers

DOI

1 reference

31 October 2017

1 reference